<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2025_3_73</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-472</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>ЗНАЧЕНИЕ SNP ГЕНА ИНТЕРЛЕЙКИНА-4–589C&gt;T И ГЕНА ФАКТОРА НЕКРОЗА ОПУХОЛИ-АЛЬФА–308G&gt;A В ПАТОГЕНЕЗЕ ПЕРИПРОТЕЗНОЙ ИНФЕКЦИИ У ПАЦИЕНТОВ ПОСЛЕ ЭНДОПРОТЕЗИРОВАНИЯ КРУПНЫХ СУСТАВОВ ПРИ ПЕРВИЧНОМ ОСТЕОАРТРИТЕ</article-title><trans-title-group xml:lang="en"><trans-title>THE SIGNIFICANCE OF THE INTERLEUKIN-4 GENE SNP–589C&gt;T AND THE TUMOR NECROSIS FACTOR-ALPHA GENE–308G&gt;A IN THE PATHOGENESIS OF PERIPROSTHETIC INFECTION IN PATIENTS AFTER LARGE JOINT RESTORATION WITH PRIMARY OSTEOARTHRITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1432-1844</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманов</surname><given-names>А. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanov A.M.,</surname><given-names>A. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мироманов Александр Михайлович, д.м.н., профессор, первый проректор, проректор по лечебной работе, заведующий кафедрой травматологии и ортопедии</p><p>672000, г. Чита, ул. Горького, д. 39а</p></bio><bio xml:lang="en"><p>Miromanov A.M., Doctor of Medical Sciences, Professor, First Vice-Rector, Vice-Rector for Medical Work, Head of the Department of Traumatology and Orthopedics</p><p>39a Gorky St., Chita, Russia, 672000</p></bio><email xlink:type="simple">miromanov_a@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-9338-1646</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ешидоржиев</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Yeshidorzhiev</surname><given-names>D. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ешидоржиев Дамдин Альбертович, аспирант кафедры травматологии и ортопедии</p><p>672000, г. Чита, ул. Горького, д. 39а</p></bio><bio xml:lang="en"><p>Eshidorzhiev D.A., Postgraduate student of the Department of Traumatology and Orthopedics</p><p>39a Gorky St., Chita, Russia, 672000</p></bio><email xlink:type="simple">damdin_albertovich@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1684-6249</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Миронова</surname><given-names>О. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Mironova</surname><given-names>O. B.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Миронова Ольга Борисовна, к.м.н., доцент, доцент кафедры травматологии и ортопедии</p><p>672000, г. Чита, ул. Горького, д. 39а</p></bio><bio xml:lang="en"><p>Mironova O.B., Сandidate of Medical Sciences, Associate Professor, Associate Professor of the Department of Traumatology and Orthopedics</p><p>39a Gorky St., Chita, Russia, 672000</p></bio><email xlink:type="simple">omironova4@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2109-4643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мироманова Наталья Анатольевна, д.м.н., доцент, заведующая кафедрой детских инфекций</p><p>672000, г. Чита, ул. Горького, д. 39а</p></bio><bio xml:lang="en"><p>Miromanova N.A., Doctor of Medical Sciences, Associate Professor, Head of the Department of Pediatric Infections</p><p>39a Gorky St., Chita, Russia, 672000</p></bio><email xlink:type="simple">detinf-chita@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>02</day><month>11</month><year>2025</year></pub-date><volume>0</volume><issue>3</issue><fpage>73</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Мироманов А.М., Ешидоржиев Д.А., Миронова О.Б., Мироманова Н.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Мироманов А.М., Ешидоржиев Д.А., Миронова О.Б., Мироманова Н.А.</copyright-holder><copyright-holder xml:lang="en">Miromanov A.M., A.M., Yeshidorzhiev D.A., Mironova O.B., Miromanova N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/472">https://www.zabmedvestnik.ru/jour/article/view/472</self-uri><abstract><p>Цель исследования – установить значение SNP гена IL-4(C589T) и TNFα(G308A) в патогенезе перипротезной инфекции у пациентов после эндопротезирования крупных суставов при первичном остеоартрите.Материалы и методы. Обследовано 182 неродственных пациентов среднего (45–59) и пожилого (60–74) возраста, с первичным остеоартритом крупных суставов III стадии, которым выполнено тотальное эндопротезирование. 1 группа (n = 92) – пациенты с неосложнённым течением. 2 группа (n = 90) – пациенты с развитием перипротезной инфекции. Контрольная группа – 92 практически здоровых лица. Методы исследования: клинические; лабораторные (иммунологический – определение IL-4, TNF-α; генетический – полиморфизм гена IL-4(C589T), TNFα(G308A)); инструментальные (рентгенография). Статистическая обработка результатов исследования проводилась с помощью пакета программ IBM SPSS Statistics Version 25.0 (IBM, США).Результаты. У пациентов с неосложнённым течением послеоперационного периода после эндопротезирования крупных суставов при первичном остеоартрите выявлено преобладание -589С-аллели, -589С/С генотипа гена IL-4 и -308G- аллели, -308G/G генотипа гена TNFα. Установлено повышение уровня IL-4 и TNFα на 10 сутки послеоперационного периода в первой и второй группах относительно контрольных значений и отсутствие различий между клиническими группами. Носительство мутантного генотип гена IL-4(C589T) способствует снижению содержания кодируемого белка, а носительство мутантного генотипа гена TNFα(G308A) характеризуется повышением концентрации TNF-α.Заключение. Аллель -589Т-, генотип -589Т/Т гена IL-4 и аллель -308А- и генотип -308А/А гена TNFα ассоциируется с развитием перипротезной инфекции у пациентов после эндопротезирования при первичном остеоартрите. У пациентов на 10 сутки послеоперационного периода регистрируется повышение концентрации IL-4 и TNFα по сравнению с контрольными значениями. При носительстве генотипа -589Т/Т гена IL-4 отмечается снижение уровня IL-4 в сыворотке крови, тогда как при носительстве генотипа -308А/А гена TNFα – повышение содержания TNF-α.</p></abstract><trans-abstract xml:lang="en"><p>The aim of the study is to establish the significance of SNP of the IL-4 (C589T) and TNFα (G308A) gene in the pathogenesis of periprosthetic infection in patients after endoprosthetics of large joints with primary osteoarthritis.Materials and methods. The study included 182 unrelated patients of middle (45–59) and elderly (60–74) age with primary osteoarthritis of large joints stage III who underwent total joint arthroplasty. Group 1 (n = 92) – patients with uncomplicated course. Group 2 (n = 90) – patients with development of periprosthetic infection. Control group – 92 practically healthy individuals. Research methods: clinical; laboratory (immunological – determination of IL-4, TNF-α; genetic – polymorphism of the gene IL-4 (C589T), TNFα (G308A)); instrumental (radiography). Statistical processing of the study results was performed using the IBM SPSS Statistics Version 25.0 software package (IBM, USA).Results. In patients with an uncomplicated postoperative period after endoprosthetics of large joints for primary osteoarthritis, a predominance of the -589C- allele, -589C/C genotype of the IL-4 gene and the -308G- allele, -308G/G genotype of the TNFα gene was revealed. An increase in the level of IL-4 and TNFα on the 10th day of the postoperative period was established in the first and second groups relative to the control values, and no differences were found between the clinical groups. Carriage of the mutant genotype of the IL-4 gene (C589T) contributes to a decrease in the content of the encoded protein, and carriage of the mutant genotype of the TNFα gene (G308A) is characterized by an increase in the concentration of TNF-α.Conclusion. The -589T- allele, -589T/T genotype of the IL-4 gene, and the -308A- allele and -308A/A genotype of the TNFα gene are associated with the development of periprosthetic joint infection in patients after endoprosthetics for primary osteoarthritis. In patients, elevated IL-4 and TNFα concentrations are recorded on the tenth postoperative day compared to control values. Carriers of the -589T/T genotype of the IL-4 gene are characterized by decreased IL-4 levels in the blood serum, while carriers of the -308A/A genotype of the TNFα gene are characterized by elevated TNF-α levels.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>полиморфизм генов</kwd><kwd>цитокины</kwd><kwd>перипротезная инфекция</kwd><kwd>эндопротезирование</kwd><kwd>первичный остеоартрит</kwd><kwd>патогенез</kwd></kwd-group><kwd-group xml:lang="en"><kwd>gene polymorphism</kwd><kwd>cytokines</kwd><kwd>periprosthetic infection</kwd><kwd>endoprosthetics</kwd><kwd>primary osteoarthritis</kwd><kwd>pathogenesis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено при финансовой поддержке ФГБОУ ВО «Читинская государственная медицинская академия»</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации Министерства здравоохранения Российской Федерации. Коксартроз. URL: https://cr.minzdrav.gov.ru/preview-cr/870_1 (дата обращения: 17.09.2025).</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines of the Ministry of Health of the Russian Federation. Coxarthrosis. URL: https://cr.minzdrav.gov.ru/preview-cr/870_1 (accessed: 17.09.2025) In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Клинические рекомендации Министерства здравоохранения Российской Федерации. Гонартроз. URL: https://cr.minzdrav.gov.ru/preview-cr/868_1 (дата обращения: 17.09.2025).</mixed-citation><mixed-citation xml:lang="en">Clinical guidelines of the Ministry of Health of the Russian Federation. Gonarthrosis. URL: https://cr.minzdrav.gov.ru/preview-cr/868_1 (accessed: 17.09.2025). In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Любимова Л.В., Павлова С.И., Николаев Н.С., и соавт. Возможность использования синовиальных С-реактивного белка, интерлейкина-6 и пресепсина в диагностике перипротезной инфекции. Травматология и ортопедия России. 2024. 30 (4). 5–13. doi: 10.17816/2311-2905-17578.</mixed-citation><mixed-citation xml:lang="en">Lyubimova L.V., Pavlova S.I., Nikolaev N.S., et al. Possibility of using synovial C-reactive protein, interleukin-6 and presepsin in the diagnosis of periprosthetic infection. Traumatology and Orthopedics of Russia. 2024. 30 (4). 5–13. doi: 10.17816/2311-2905-17578. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Кетлинский С.А., Симбирцев А.С. Цитокины. Санкт-Петербург: Фолиант. 2008. 552. ISBN 978-5-93929-171-2.</mixed-citation><mixed-citation xml:lang="en">Ketlinsky S.A., Simbirtsev A.S. Cytokines. St. Petersburg: Foliant. 2008. 552. ISBN 978-5-93929-171-2. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Указ Президента Российской Федерации 18.06.2024 № 529. Об утверждении приоритетных направлений научно-технологического развития и перечня важнейших наукоёмких технологий. URL: http://www.kremlin.ru/acts/bank/50755 (дата обращения: 17.09.2025).</mixed-citation><mixed-citation xml:lang="en">Decree of the President of the Russian Federation of June 18, 2024, No. 529. On approval of priority areas of scientific and technological development and the list of the most important science-intensive technologies. URL: http://www.kremlin.ru/acts/bank/50755 (date of access: September 17, 2025). In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Crawley F.P. Declaration of Helsinki: Full paragraph-by-paragraph comparison indicating changes in version 19 October 2024 compared with the most previous version of 19 October 2013. Zenodo. 2024. URL: https://doi.org/10.5281/zenodo.13997192 (date of access: 13.05.2025).</mixed-citation><mixed-citation xml:lang="en">Crawley F.P. Declaration of Helsinki: Full paragraph-by-paragraph comparison indicating changes in version 19 October 2024 compared with the most previous version of 19 October 2013. Zenodo. 2024. URL: https://doi.org/10.5281/zenodo.13997192 (date of access: 13.05.2025).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">McNally M., Sousa R., Wouthuyzen-Bakker M., et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021. 103-B (1). 18–25. doi: 10.1302/0301-620X.103B1.BJJ-2020-1381.R1.</mixed-citation><mixed-citation xml:lang="en">McNally M., Sousa R., Wouthuyzen-Bakker M., et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021. 103–B (1). 18–25. doi: 10.1302/0301-620X.103B1.BJJ-2020-1381.R1.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Мудров В.А. Алгоритмы статистического анализа данных биомедицинских исследований с помощью пакета программ SPSS (доступным языком). Москва. Логосфера. 2022. 143. ISBN 9785986570884.</mixed-citation><mixed-citation xml:lang="en">Mudrov V.A. Algorithms for statistical analysis of biomedical research data using the SPSS software package (in accessible language). Moscow. Logosfera. 2022. 143. ISBN 9785986570884. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jamshidy L., Tadakamadla S.K., Choubsaz P., Sadeghi M., Tadakamadla J. Association of IL-10 and TNF-α polymorphisms with dental peri-implant disease risk: a meta-analysis, meta-regression, and trial sequential analysis. Int J Environ Res Public Health. 2021. 18 (14). 7697. doi: 10.3390/ijerph18147697.</mixed-citation><mixed-citation xml:lang="en">Jamshidy L., Tadakamadla S.K., Choubsaz P., Sadeghi M., Tadakamadla J. Association of IL-10 and TNF-α polymorphisms with dental peri-implant disease risk: a meta-analysis, meta-regression, and trial sequential analysis. Int J Environ Res Public Health. 2021. 18 (14). 7697. doi: 10.3390/ijerph18147697.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Мироманов А.М., Миронова О.Б., Мироманова Н.А. Полиморфизм гена интерлейкина-4-589C&gt;T и экспрессия интерлейкина-4 у пациентов с развитием хронического травматического остеомиелита. Медицинская иммунология. 2018. 20 (6). 889–894. doi: 10.15789/1563-0625-2018-6-889-894.</mixed-citation><mixed-citation xml:lang="en">Miromanov A.M., Mironova O.B., Miromanova N.A. IL4-589C&gt;T gene polymorphism and expression of interleukin-4 in patients with developing chronic traumatic osteomyelitis. Medical Immunology (Russia). Meditsinskaya Immunologiya. 2018. 20 (6). 889–894. doi: 10.15789/1563-0625-2018-6-889-894. In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Мироманов А.М., Миронова О.Б., Мироманова Н.А., Трубицын М.В. Влияние полиморфизма гена TNFα – 308G&gt;A на экспрессию TNFα у больных с развитием хронического травматического остеомиелита в Забайкальском крае. Фундаментальные исследования. 2015. 1 (4). 783–788.</mixed-citation><mixed-citation xml:lang="en">Miromanov A.M., Mironova O.B., Miromanova N.A., Trubitsyn M.V. The influence of the TNFα gene polymorphism – 308G&gt;A on the expression of TNFα in patients with the development of chronic traumatic osteomyelitis in the Trans-Baikal Territory. Fundamental research. 2015. 1 (4). 783–788 In Russian.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Zhen L., Sun Y., Gao J. Interleukin 4 gene polymorphisms and the risk of tuberculosis: а meta-analysis. Cytokine. 2023.169. 156282. doi: 10.1016/j.cyto.2023.156282.</mixed-citation><mixed-citation xml:lang="en">Zhen L., Sun Y., Gao J. Interleukin 4 gene polymorphisms and the risk of tuberculosis: а meta-analysis. Cytokine. 2023. 169. 156282. doi: 10.1016/j.cyto.2023.156282.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brown M.A., Hural J. Functions of IL-4 and Control of Its Expression. Crit Rev Immunol. 2017. 37 (2–6). 181–212. doi: 10.1615/CritRevImmunol.v37.i2-6.30.</mixed-citation><mixed-citation xml:lang="en">Brown M.A., Hural J. Functions of IL-4 and Control of Its Expression. Crit Rev Immunol. 2017. 37 (2–6). 181–212. doi: 10.1615/CritRevImmunol.v37.i2-6.30.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang X., Zhu X., Sun W. Association between tumor necrosis factor-α (G-308A) polymorphism and chronic periodontitis, aggressive periodontitis, and peri-implantitis: a meta-analysis. J Evid Based Dent Pract. 2021. 21 (3). 101528. doi: 10.1016/j.jebdp.2021.101528.</mixed-citation><mixed-citation xml:lang="en">Zhang X., Zhu X., Sun W. Association between tumor necrosis factor-α (G-308A) polymorphism and chronic periodontitis, aggressive periodontitis, and peri-implantitis: a meta-analysis. J Evid Based Dent Pract. 2021. 21 (3). 101528. doi: 10.1016/j.jebdp.2021.101528.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Chmielewski M., Pilloni A. Current molecular, cellular and genetic aspects of peri-implantitis disease: a narrative review. Dent J (Basel). 2023. 11 (5). 134. doi: 10.3390/dj11050134.</mixed-citation><mixed-citation xml:lang="en">Chmielewski M., Pilloni A. Current molecular, cellular and genetic aspects of peri-implantitis disease: a narrative review. Dent J (Basel). 2023. 11 (5). 134. doi: 10.3390/dj11050134.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lafuente-Ibáñez de Mendoza I., Setien-Olarra A., García-De la Fuente A.M., Aguirre‐Urizar J.M., Marichalar-Mendia X. Role of proinflammatory mutations in peri-implantitis: systematic review and meta-analysis. Int J Implant Dent 8. 2. 2022. https://doi.org/10.1186/s40729-022-00400-y.</mixed-citation><mixed-citation xml:lang="en">Lafuente-Ibáñez de Mendoza I., Setien-Olarra A., García-De la Fuente A.M., Aguirre‐Urizar J.M., Marichalar-Mendia X. Role of proinflammatory mutations in peri-implantitis: systematic review and meta-analysis. Int J Implant Dent 8, 2 (2022). https://doi.org/10.1186/s40729-022-00400-y.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y., Ling J., Jiang Q. Inflammasomes in alveolar bone loss. Front Immunol. 2021. 12. 691013. doi: 10.3389/fimmu.2021.691013.</mixed-citation><mixed-citation xml:lang="en">Li Y., Ling J., Jiang Q. Inflammasomes in alveolar bone loss. Front Immunol. 2021. 12. 691013. doi: 10.3389/fimmu.2021.691013.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Alippe Y., Mbalaviele G. Omnipresence of inflammasome activities in inflammatory bone diseases. Semin Immunopathol. 2019. 41 (5). 607–618. doi: 10.1007/s00281-019-00753-4.</mixed-citation><mixed-citation xml:lang="en">Alippe Y., Mbalaviele G. Omnipresence of inflammasome activities in inflammatory bone diseases. Semin Immunopathol. 2019. 41 (5). 607–618. doi: 10.1007/s00281-019-00753-4.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Rasmussen G., Idosa B.A., Bäckman A., et al. Caspase-1 inflammasome activity in patients with Staphylococcus aureus bacteremia. Microbiol Immunol. 2019. 63 (12). 487–499. doi: 10.1111/1348-0421.</mixed-citation><mixed-citation xml:lang="en">Rasmussen G., Idosa B.A., Bäckman A., et al. Caspase-1 inflammasome activity in patients with Staphylococcus aureus bacteremia. Microbiol Immunol. 2019. 63 (12). 487–499. doi: 10.1111/1348-0421.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Peng L., Jiang J., Chen T., et al. Toxic shock syndrome toxin 1 induces immune response via the activation of NLRP3 inflammasome. Toxins (Basel). 2021. 13 (1). 68. doi: 10.3390/toxins13010068.</mixed-citation><mixed-citation xml:lang="en">Peng L., Jiang J., Chen T., et al. Toxic shock syndrome toxin 1 induces immune response via the activation of NLRP3 inflammasome. Toxins (Basel). 2021. 13 (1). 68. doi: 10.3390/toxins13010068.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hedrich C.M., Morbach H., Reiser C., Girschick H.J. New insights into adult and paediatric chronic nonbacterial osteomyelitis cno. Curr Rheumatol Rep. 2020. 22 (9). 52. doi: 10.1007/s11926-020-00928-1.</mixed-citation><mixed-citation xml:lang="en">Hedrich C.M., Morbach H., Reiser C., Girschick H.J. New insights into adult and paediatric chronic nonbacterial osteomyelitis cno. Curr Rheumatol Rep. 2020. 22 (9). 52. doi: 10.1007/s11926-020-00928-1.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y., Ferguson P.J. Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases. Clin Immunol. 2020. 216. 108458. doi: 10.1016/j.clim.2020.108458.</mixed-citation><mixed-citation xml:lang="en">Zhao Y., Ferguson P.J. Chronic non-bacterial osteomyelitis and autoinflammatory bone diseases. Clin Immunol. 2020. 216. 108458. doi: 10.1016/j.clim.2020.108458.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Buch K., Thuesen A.C.B., Brøns C., Schwarz P. Chronic non-bacterial osteomyelitis: a review. Calcif Tissue Int. 2019. 104 (5). 544–53. doi: 10.1007/s00223-018-0495-0.</mixed-citation><mixed-citation xml:lang="en">Buch K., Thuesen A.C.B., Brøns C., Schwarz P. Chronic non-bacterial osteomyelitis: a review. Calcif Tissue Int. 2019. 104 (5). 544–53. doi: 10.1007/s00223-018-0495-0.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Hofmann S.R., Kapplusch F., Mäbert K., Hedrich C.M. The molecular pathophysiology of chronic nonbacterial osteomyelitis (CNO)-a systematic review. Mol Cell Pediatr. 2017. 4 (1). 7. doi: 10.1186/s40348-017-0073-y.</mixed-citation><mixed-citation xml:lang="en">Hofmann S.R., Kapplusch F., Mäbert K., Hedrich C.M. The molecular pathophysiology of chronic nonbacterial osteomyelitis (CNO)-a systematic review. Mol Cell Pediatr. 2017. 4 (1). 7. doi: 10.1186/s40348-017-0073-y.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Brandt D., Sohr E., Pablik J., et al. CD14+ monocytes contribute to inflammation in chronic nonbacterial osteomyelitis (CNO) through increased NLRP3 inflammasome expression. Clin Immunol. 2018. 196. 77–84. doi: 10.1016/j.clim.2018.04.011.</mixed-citation><mixed-citation xml:lang="en">Brandt D., Sohr E., Pablik J., et al. CD14+ monocytes contribute to inflammation in chronic nonbacterial osteomyelitis (CNO) through increased NLRP3 inflammasome expression. Clin Immunol. 2018. 196. 77–84. doi: 10.1016/j.clim.2018.04.011.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bressan E., Ferroni L., Gardin C., et al. Metal nanoparticles released from dental implant surfaces: potential contribution to chronic inflammation and peri-implant bone loss. Materials (Basel). 2019. 12 (12). 2036. doi: 10.3390/ma12122036.</mixed-citation><mixed-citation xml:lang="en">Bressan E., Ferroni L., Gardin C., et al. Metal nanoparticles released from dental implant surfaces: potential contribution to chronic inflammation and peri-implant bone loss. Materials (Basel). 2019. 12 (12). 2036. doi: 10.3390/ma12122036.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
